LEMAITRE VASCULAR, INC. Shareholders' Equity
LEMAITRE VASCULAR, INC. (LMAT) had Shareholders' Equity of $420.34 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $420.34M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $406.62M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $393.52M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $378.92M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $420.34M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $406.62M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $393.52M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $378.92M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $362.69M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $347.57M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $337.29M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $331.07M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $319.53M 10-Q · filed 2025-11-07 |
| 2024-03-31 | $308.50M 10-Q · filed 2025-11-07 |
| 2023-12-31 | $297.90M 10-K · filed 2026-02-26 |
| 2023-09-30 | $288.64M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $283.83M 10-Q · filed 2024-11-08 |
| 2023-03-31 | $274.17M 10-Q · filed 2024-11-08 |
| 2022-12-31 | $268.20M 10-K · filed 2026-02-26 |
| 2022-09-30 | $261.25M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $258.03M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $257.79M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $254.15M 10-K · filed 2025-02-28 |
| 2021-09-30 | $249.05M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $185.83M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $177.53M 10-Q · filed 2022-11-08 |
| 2020-12-31 | $172.57M 10-K · filed 2024-02-29 |
| 2020-09-30 | $160.98M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $152.63M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $148.84M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $148.14M 10-K · filed 2023-03-01 |
| 2019-09-30 | $142.32M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $137.54M 10-Q · filed 2020-11-06 |
| 2019-03-31 | $133.09M 10-Q · filed 2020-11-06 |
| 2018-12-31 | $130.24M 10-K · filed 2022-02-28 |
| 2018-09-30 | $125.35M 10-Q · filed 2019-11-08 |
| 2018-06-30 | $120.74M 10-Q · filed 2019-11-08 |
| 2018-03-31 | $113.47M 10-Q · filed 2019-11-08 |
| 2017-12-31 | $109.77M 10-K · filed 2021-03-12 |
| 2017-09-30 | $106.11M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $98.31M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $91.62M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $87.50M 10-K · filed 2020-03-12 |
| 2016-09-30 | $86.69M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $82.85M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $80.62M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $77.88M 10-K · filed 2019-03-11 |
| 2015-09-30 | $74.19M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $70.44M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $67.93M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $68.21M 10-K · filed 2018-03-09 |
| 2014-09-30 | $67.12M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $67.78M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $56.24M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $56.56M 10-K · filed 2017-03-09 |
| 2013-09-30 | $55.39M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $54.13M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $53.34M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $52.89M 10-K · filed 2016-03-10 |
| 2012-09-30 | $51.91M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $51.97M 10-Q · filed 2012-08-10 |
| 2012-03-31 | $52.05M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $52.09M 10-K · filed 2015-03-18 |
| 2011-09-30 | $52.65M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $52.80M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $52.36M 10-K · filed 2014-03-21 |
| 2009-12-31 | $48.21M 10-K · filed 2013-03-27 |
| 2008-12-31 | $45.75M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |